All rights reserved and protected - you may LINK to this site

Our mission is to bring to your attention Mesothelioma News and views from leading medical and legal sources. What is Mesothelioma, What are the symptoms of Mesothelioma, what treatments are available, what should you do when you develop some of the symptoms, what medical help is available, when should you see a Mesothelioma Lawyer, how long does it take for a Mesothelioma claim to be processed ... and a lot more of your questions.

We bring Mesothelioma resources and experts to your attention. Get Mesothelioma help from experts who will guide you on a one to one basis, and step by step. Please bookmark this page now for updates.

Mesothelioma In The News ... see below

Mesothelioma: Frequently Asked Questions and Answers - Mesothelioma Cancer FAQs

New technique can help diagnose mesothelioma ...

Asbestos Litigation Conference ...

Earlier Detection of Asbestos-Related Diseases ...

Mesothelioma Patient and Caregiver ...

Asbestos Lawyers, Attorneys and Litigators ...

International Mesothelioma Program's Annual Harvard Medical School Course

Asbestos Awareness Day Conference and Remembrance, National Asbestos Awareness Week

Mesothelioma, Mesothelioma Lawyers and legal tips

Asbestos, Clean-Up Plan for Debris and Equipment That Tested Positive for Asbestos

Asbestos Claims Under Fairness In Asbestos Injury Resolution Act

Fairness in Asbestos Injury Resolution

Asbestos Regulations, Asbestos Approved Code of Practice

Asbestos Mesothelioma Compensation Claims

Asbestos Mesothelioma - some quick facts

Mesothelioma Legal Claim, Jurisdiction, Damages

Lung Cancer News, Non-Small Cell Lung Cancer, NSCLC

Diagnosis and treatment of an aggressive asbestos-related cancer

Lungs, Pleura, Mesothelioma Guides

Lung Cancer And Mesothelioma Guides

Asbestos Guides, Asbestos Research and Asbestos References

Mesothelioma, Safety Guidelines, airborne hazards, asbestos

Mesothelioma, Malignant Mesothelioma, Mesothelioma International Symposium

Mesothelioma, Anti-Cancer Agent

Mesothelioma, Focus on Cure

Mesothelioma Research

Asbestos Litigation

Detection, Prevention, Treatment and Cure of Mesothelioma

Mesothelioma - First Therapy

Mesothelioma Attorneys

Malignant Mesothelioma

Mesothelioma - Asbestos Awareness

Mesothelioma Resources

Mesothelioma: Asbestos - Resources and Research

Mesothelioma, Asbestos and other topics In the news

Mesothelioma likely result of asbestos in environment

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite asbestos, erionite, winchite, magnesioriebeckite and richterite were discovered. Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.

Steel Workers' Families Win $3.9M In Asbestos Case. CBS 13 Baltimore

Gloucestershire inquest returns open verdict on teacher's death from asbestos / mesothelioma cancer. Gazette Series UK

Reed Smith LLP has opened of a Paris office. The new office will handle a variety of work including asbestos litigation.

Women Impacting Public Policy called on Senate Majority Leader Bill Frist to quickly bring the Fairness in Asbestos Injury Resolution (FAIR) Act to the Senate floor for a vote. Many small businesses are suffering under the weight of the asbestos litigation system, WIPP said in its letter to Senator Frist.

NeoRx Corporation has received orphan drug designation from the Office of Orphan Products Development at the U.S. Food and Drug Administration for the Company's investigational product picoplatin, a next-generation platinum therapy, for the treatment of small cell lung cancer (SCLC).

The Food and Drug Administration should use extraordinary measures, including lower regulatory barriers, to release eight anti-cancer vaccines that have stalled in developer pipelines, according to an agency "whistleblower" reported in the online FDA news service.

Asbestos-related and other fatal diseases

"Several thousand people die each year from diseases caused by past work exposures, including nearly 1900 deaths in 2003 from mesothelioma, a cancer related to asbestos exposure." HSE UK

November is Lung Cancer Awareness Month

SimmonsCooper LLC has pledged $10.2 million to fund a new cancer institute at Southern Illinois University (SIU).

The institute, which will be named The SimmonsCooper Cancer Institute at SIU, will provide extraordinary new resources to enhance treatments and implement the continuing search for a permanent cancer cure.

The American Small Businesses Association called on Senate Majority Leader Bill Frist to push for asbestos litigation reform.

The Health and Safety Commission (HSC UK) published a consultative document seeking comments on proposed amendments to its asbestos regulations and an Approved Code of Practice (ACoP).

The worldwide market for in vitro cancer diagnosis will reach the $7.4 billion mark by 2009, according to a new study just released by Kalorama Information. As the demand for more sophisticated diagnostics continues to grow and synergies between tests and new therapeutics emerge, IVD tests for cancer will continue to see a 13% annual growth.

Scot C. Remick, MD, Director of Developmental Therapeutics at the Ireland Cancer Center of University Hospitals of Cleveland and the Case Comprehensive Cancer Center, has been named the first incumbent to the Dr. Lester E. Coleman, Jr. Chair in Cancer Research and Therapeutics. The Coleman chair was established in memory of Lester E. Coleman, PhD, former chairman and chief executive officer of the Lubrizol Corporation, who chose to participate in clinical trials in his battle against lung cancer.

Acute Lung Injury mortality Is 4-fold higher than from heart attack and comparable to breast cancer and HIV, according to an article in the New England Journal of Medicine

Alimta - treatment for malignant pleural mesothelioma

For the third quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small cell lung cancer, generated sales of $122.3 million, representing a sequential increase of 10 percent compared with second-quarter 2005 sales of $111.2 million. In the third quarter, U.S. sales of Alimta were $76.9 million and sales outside the U.S. were $45.4 million.   Eli Lilly and Company

Mesothelioma Attorneys